Price T Rowe Associates Inc Innoviva, Inc. Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
A detailed history of Price T Rowe Associates Inc transactions in Innoviva, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 51,487 shares of INVA stock, worth $849,535. This represents 0.0% of its overall portfolio holdings.
Number of Shares
51,487
Previous 49,606
3.79%
Holding current value
$849,535
Previous $796,000
1.38%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding INVA
# of Institutions
220Shares Held
78.8MCall Options Held
45.9KPut Options Held
14.1K-
Black Rock Inc. New York, NY10.1MShares$167 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT7.28MShares$120 Million19.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.29MShares$104 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA6.27MShares$103 Million0.03% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$103 Million0.14% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.15B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...